Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 17/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7207844 | 0.89 | PTGER1 (0.41) | PTGER1 | |
| SCHEMBL7208501 | 0.88 | CETP (0.37) | PTGER1 | |
| SCHEMBL7212901 | 0.83 | PTGER1 (0.39) | PTGER1 | |
| SCHEMBL7209116 | 0.82 | GAA (0.38) | PTGER1 | |
| SCHEMBL7506976 | 0.82 | PTGER1 (0.37) | PTGER1 | |
| SCHEMBL8058096 | 0.81 | CETP (0.38) | PTGER1 | |
| SCHEMBL7208535 | 0.79 | CETP (0.35) | PTGER1 | |
| SCHEMBL7207878 | 0.78 | CETP (0.37) | PTGER1 | |
| SCHEMBL7209076 | 0.78 | GAA (0.37) | PTGER1 | |
| SCHEMBL7212720 | 0.78 | CETP (0.38) | PTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1056754-B1 | PHOSPHATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | BRISTOL MYERS SQUIBB CO (US) | 2003-10-22 | — | — | EP | disclosed |
| EP-1056754-A4 | PHOSPHATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | BRISTOL MYERS SQUIBB CO (US) | 2002-03-06 | — | — | EP | disclosed |
| EP-1056754-A1 | PHOSPHATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | Bristol-Myers Squibb Company (US) | 2000-12-06 | — | — | EP | disclosed |
| WO-1999038873-A1 | PHOSPHATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-08-05 | — | — | WO | disclosed |